Skip to content
  • HOME
  • ABOUT

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    LEARN MORE ➔
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    CPA Questions China Commission’s Push to Invest in Indian Drug Manufacturing

    CPA Questions China Commission’s Push to Invest in Indian Drug Manufacturing

    November 20, 2026

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    CPA Questions China Commission’s Push to Invest in Indian Drug Manufacturing

    Congress Should Fix Tariff Policy, Not Abolish It

    China’s Fertilizer Export Restrictions Are Still in Place and Harming American Agriculture

    Blaming Tariffs Won’t Fix the Cost-of-Living Crisis

    MORE FROM THE NEWSROOM ➔
  • RESEARCH
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

CPA Questions China Commission’s Push to Invest in Indian Drug Manufacturing

CPA Questions China Commission’s Push to Invest in Indian Drug Manufacturing

Archive, China, CPA News, Featured Home Page, Guest Opinion & Press Releases, Healthcare, Industrial Policy, Manufacturing, Newsroom, Press Release, Supply ChainBy CPA NewsroomNovember 20, 2026

India’s antibiotic supply chain runs through China, and its plants carry a long record of FDA violations.

  • ABOUT
  • NEWSROOM
  • CONTACT
Facebook-f Youtube Linkedin

© 2026 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • STAFF
    • BOARD
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • RESEARCH
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Share This
 Facebook
 LinkedIn
 Copy

Share on Mastodon